World's Best Scientists 2026 revealed!

Philip Rubin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Philip Rubin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

The last bar groups every scientist with 1,796 publications or more.

Philip Rubin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Philip Rubin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

The last bar groups every scientist with 217 D-Index or more.

Overview

Philip Rubin was affiliated with the University of Rochester Medical Center in the United States. Their research work spanned several interconnected areas primarily within the field of Medicine, with a focus on Oncology, Infectious Diseases, Public Health, Environmental and Occupational Health, and Experimental and Cognitive Psychology.

The scientist contributed to multiple topics throughout their career. These included:

  • COVID-19 and healthcare impacts
  • COVID-19 Clinical Research Studies
  • Palliative Care and End-of-Life Issues
  • Phonetics and Phonology Research

Among the most recent papers authored or coauthored by Philip Rubin were:

  • Clinical Determinants Differentiating the Severity of SARS-CoV-2 Infection in Cancer Patients: Hospital Care or Home Recovery, 2021, published in Frontiers in Medicine
  • Arthur Abramson, 2022, published in the Oxford Research Encyclopedia of Linguistics

Frequent coauthors who collaborated with them include:

  • Dong D. Lin
  • Yunhong Wu
  • Sudhamshi Toom
  • Niki Sheth
  • Kevin Becker

The scholar's research was disseminated in venues such as:

  • Frontiers in Medicine
  • Oxford Research Encyclopedia of Linguistics

Their interdisciplinary work combined clinical research related to COVID-19 with language and phonetics research, reflecting a range that covers both health sciences and cognitive studies. The publications indicate an involvement in clinical research addressing the severity of COVID-19 infections among vulnerable populations, as well as contributions to linguistic encyclopedias.

Best Publications

  • CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

    Andy Trotti;A.Dimitrios Colevas;Ann Setser;Valerie Rusch

  • Long‐term observations of the patterns of failure in patients with unresectable non‐oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology group

    Carlos A. Perez;Thomas F. Pajak;Philip Rubin;Joseph R. Simpson

  • Hypothalamic-Pituitary Dysfunction After Radiation for Brain Tumors

    Louis S. Constine;Paul D. Woolf;Donald Cann;Gail Mick

  • Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology group

    Miljenko V. Pilepich;William T. Sause;William U. Shipley;John M. Krall

  • A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the radiation therapy oncology group

    C. A. Perez;K. Stanley;P. Rubin;S. Kramer

  • Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706

    Colleen A. Lawton;Minhee Won;Miljenko V. Pilepich;Sucha O. Asbell

  • Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung: report by the Radiation Therapy Oncology Group.

    Carlos A. Perez;Kenneth Stanley;Graham Grundy;William Hanson

  • Injury to the lung from cancer therapy: Clinical syndromes, measurable endpoints, and potential scoring systems

    Sandra McDonald;Philip Rubin;Theodore L. Phillips;Lawrence B. Marks

  • RTOG Late Effects Working Group. Overview. Late Effects of Normal Tissues (LENT) scoring system.

    Philip Rubin;Louis S. Constine;Luis F. Fajardo;Theodore L. Phillips

  • Radiation pneumonitis and early circulatory cytokine markers

    Yuhchyau Chen;Jacqueline Williams;Ivan Ding;Eric Hernady

  • Adverse effects of brain irradiation correlated with MR and CT imaging.

    L.S. Constine;A. Konski;S. Ekholm;S. McDonald

  • Quality assurance problems in clinical hyperthermia and their impact on therapeutic outcome: A report by the radiation therapy oncology group

    Carlos A. Perez;Brenda Gillespie;Thomas Pajak;Ned B. Hornback

  • Early and persistent alterations in the expression of interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor alpha mRNA levels in fibrosis-resistant and sensitive mice after thoracic irradiation.

    Carl J. Johnston;Bruno Piedboeuf;Philip Rubin;Jacqueline P. Williams

  • Improved survival in cases of intracranial ependymoma after radiation therapy. Late report and recommendations.

    Omar M. Salazar;Hernan Castro-Vita;Paul VanHoutte;Philip Rubin

  • Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors. Final report by the Radiation Therapy Oncology Group.

    Carlos A. Perez;Thomas Pajak;Bahman Emami;Ned B. Hornback

  • Elapsed treatment days--a critical item for radiotherapy quality control review in head and neck trials: RTOG report.

    Thomas F. Pajak;George E. Laramore;Victor A. Marcial;John T. Fazekas

  • Disruption of the blood-brain barrier as the primary effect of CNS irradiation.

    P. Rubin;D.M. Gash;J.T. Hansen;D.F. Nelson

  • Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors: A prospectively controlled randomized study by the radiation therapy oncology group

    Bahman Emami;Charles Scott;Carlos A. Perez;Sucha Asbell

  • Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease

    Vernon King;Louis S. Constine;Douglas Clark;Ronald G. Schwartz

  • Correlation of radiotherapeutic parameters and treatment related morbidity--analysis of RTOG Study 77-06

    M.V. Pilepich;S.O. Asbell;J.M. Krall;W.H. Baerwald

Frequent Co-Authors

Louis S. Constine
Louis S. Constine University of Rochester Medical Center
Paul Okunieff
Paul Okunieff University of Florida
Carlos A. Perez
Carlos A. Perez The University of Texas Health Science Center at Houston
Thomas F. Pajak
Thomas F. Pajak RTOG Foundation
James D. Cox
James D. Cox The University of Texas MD Anderson Cancer Center
Theodore L. Phillips
Theodore L. Phillips University of California, San Francisco
Walter J. Curran
Walter J. Curran Emory University
John M. Bennett
John M. Bennett University of Rochester Medical Center
Harry Bartelink
Harry Bartelink Antoni van Leeuwenhoek Hospital
Ron Waksman
Ron Waksman MedStar Washington Hospital Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in medicine, but looking for flexible study options? There are a range of online degrees and certification programs related to healthcare that can open doors to dynamic careers. For example, pharm d online programs offer an accessible way for students to become practicing pharmacists while balancing work and personal commitments.

If you are passionate about data and healthcare management, earning a bachelor of health information management online can prepare you for roles in organizing and securing patient information within medical facilities.

For those seeking a quicker entry into the healthcare field, exploring medical billing and coding online courses cost can provide valuable training for administrative positions supporting hospitals and clinics.

Finally, for registered nurses aiming to advance their careers, the most affordable online nurse practitioner programs can help you achieve advanced clinical skills and greater responsibility in patient care settings.

These online programs give you the opportunity to grow your skills, increase your job prospects, and make an impact in healthcare—all while studying on your own terms.

Best Scientists Citing Philip Rubin

Recently Published Articles